- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01516177
Associating Renal Transplantation With the ITN Signature of Tolerance (ARTIST)
An Observational Study to Assess the Prevalence of a Tolerance Signature in Renal Transplant Recipients (ITN524ST/CTOT-12)
Studieoversikt
Status
Forhold
Detaljert beskrivelse
Following surgery, kidney transplant patients must take medications in order to prevent rejection of their transplanted organ. These medications can be very effective. Called immunosuppressive drugs, they work by reducing the activity of the immune system. Because of this, however, they can also have serious side effects, including increased risks of serious infections and certain types of cancer.
The ITN Registry of Tolerant Kidney Transplant Recipients recently identified a rare group of people whose immune system has accepted their transplant without continued use of immunosuppressive drugs. Researchers have found that these patients have a unique pattern of cells and genes expressed in their blood compared to other transplant patients.
The ARTIST study will ask the questions "Are there other transplant patients who show this pattern?" and "If so, how often?"
The goal is to find out if there are other transplant patients who are taking immunosuppression who also show this pattern of genes. If there are others, then this pattern may one day be useful in identifying transplant patients who could reduce the dose of immunosuppression they need without fear of rejection.
Researchers are seeking adults who have received a kidney transplant within the past 1 to 5 years. Participants will be asked to attend 3 short appointments with study doctors over a period of 2 years. At these visits, doctors will request demographic and clinical information, relevant medical histories and blood and urine samples. Participants will be compensated for their time.
It is important to note that this is an observational study only. Other than receiving consultations and advice from the transplant team, there is no direct medical benefit to participating. However, by participating, patients may play an active part in helping doctors learn to control kidney transplant rejection more effectively, with fewer drugs.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
Alabama
-
Birmingham, Alabama, Forente stater, 35294
- University of Alabama Birmingham
-
-
California
-
San Francisco, California, Forente stater, 94143
- University of California San Francisco
-
-
Georgia
-
Atlanta, Georgia, Forente stater, 30322
- Emory University
-
-
Illinois
-
Chicago, Illinois, Forente stater, 60611
- Northwestern University
-
-
Massachusetts
-
Boston, Massachusetts, Forente stater, 02115
- Brigham and Women's Hospital
-
Boston, Massachusetts, Forente stater, 02115
- Beth Israel Deaconess Medical Center
-
-
New York
-
New York, New York, Forente stater, 10029
- Mount Sinai School of Medicine
-
-
Ohio
-
Cleveland, Ohio, Forente stater, 44195
- The Cleveland Clinic Foundation
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
The study will include 250 participants who are determined to be eligible for further follow-up based on the eligibility criteria.
Among those eligible for further follow-up
- at least 25 participants will be renal transplant recipients who received induction therapy with Campath, and
- at least 25 participants will be renal transplant recipients who are receiving sirolimus or everolimus at time of enrollment and who have not received calcineurin inhibitors for at least 30 days prior to enrollment
Beskrivelse
Inclusion Criteria:
- Received first kidney transplant from a living or deceased donor.
- Kidney transplanted between 1 and 5 years ago.
- Calculated GFR of greater than or equal to 45 mL/min/1.73 m2 within last 6 months
- Ability to understand and provide informed consent.
Exclusion Criteria:
- History of steroid-resistant acute rejection
- History of two or more episodes of acute rejection
- Any acute rejection in the past year
- Current malignancy
- Transplant of another organ
- AIDS according to the CDC definition of AIDS.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
---|
Renal Transplant Recipients
Subjects who received a kidney transplant within the past 1 to 5 years
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
The presence of at least one time point of the previously identified renal transplant tolerance signature.
Tidsramme: 2 years
|
2 years
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
Time course of potential changes in the previously identified renal transplant tolerance signature in individual participants.
Tidsramme: 2 years
|
2 years
|
Expression levels for a wide variety of genes measured by large-scale microarray or by PCR assessments
Tidsramme: 2 years
|
2 years
|
Flow-cytometric measurements of cell populations distinguished by cell-surface phenotype
Tidsramme: 2 years
|
2 years
|
Selected clinical events and laboratory parameters to assess hematologic and renal function
Tidsramme: 2 years
|
2 years
|
Samarbeidspartnere og etterforskere
Etterforskere
- Studiestol: Kenneth Newell, MD, PhD, Emory University
- Studiestol: Laurence Turka, MD, Beth Israel Deaconess Medical Center
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- DAIT ITN524ST/CTOT-12
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Nyretransplantasjon
-
Medical University of GrazUkjentAdherence Intervention Post TransplantationØsterrike
-
Frantisek SaudekRekrutteringØyene i Langerhans TransplantationTsjekkia
-
Leiden University Medical CenterHar ikke rekruttert ennåSukkersyke | Øyene i Langerhans Transplantation | Kronisk pankreatittNederland
-
Leiden University Medical CenterPåmelding etter invitasjonSukkersyke | Øyene i Langerhans Transplantation | Pankreatitt, kroniskNederland
-
Lorenzo PiemontiAktiv, ikke rekrutterendeDiabetes mellitus, type 1 | Øyene i Langerhans TransplantationItalia
-
University of Wisconsin, MadisonBristol-Myers SquibbTilbaketrukketDiabetes mellitus, type 1 | Nyretransplantasjon | Øyene i Langerhans TransplantationForente stater
-
University of NebraskaAvsluttetDiabetes mellitus, type 1 | Øyene i Langerhans TransplantationForente stater
-
National Center for Research Resources (NCRR)Juvenile Diabetes Research FoundationUkjentØyene i Langerhans Transplantation | Diabetes mellitus, insulinavhengig | Diabetes mellitus, eksperimentell | Transplantasjon, homologForente stater
-
Medical University of ViennaFullførtSekundær hyperparathyroidisme | CKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder | NyreerstatningØsterrike